Carbazole

Carbazole

SCHEMBL170807

CC(C)[C@H](N)C(=O)O.c1ccc2c(c1)[nH]c1ccccc12

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 1/20 0.52
ALDH1A1 P00352 3/20 0.48
GPR3 P46089 1/20 0.48
HSD17B10 Q99714 1/20 0.48
KMT2A Q03164 4/20 0.46
MEN1 O00255 2/20 0.46
KIF11 P52732 2/20 0.45
POLB P06746 2/20 0.44
KDM4E B2RXH2 4/20 0.43
GABRA1 P14867 2/20 0.43
GABRG2 P18507 2/20 0.43
GABRB3 P28472 2/20 0.43
GABRA5 P31644 2/20 0.43
GABRA3 P34903 2/20 0.43
GABRA2 P47869 2/20 0.43
GABRA4 P48169 2/20 0.43
GABRA6 Q16445 2/20 0.43
MTNR1A P48039 1/20 0.43
MTNR1B P49286 1/20 0.43
GABRP O00591 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Carbazole SCHEMBL2935659 0.87 ALDH1A1 (0.54) ALDH1A1GPR3HSD17B10KMT2AMEN1
Carbazole SCHEMBL2935661 0.87 ALDH1A1 (0.54) ALDH1A1GPR3HSD17B10KMT2AMEN1
Harman SCHEMBL9150535 0.81 MAOA (0.66) ALDH1A1HSD17B10KMT2AMEN1POLB
SCHEMBL18135258 0.80 VDR (0.51) ALDH1A1KMT2AMEN1POLBKDM4E
SCHEMBL20555800 0.80 VDR (0.51) ALDH1A1KMT2AMEN1POLBKDM4E
SCHEMBL31000598 0.80 VDR (0.51) ALDH1A1KMT2AMEN1POLBKDM4E
Biphenyl SCHEMBL27824248 0.77 SLC7A5 (0.65) SLC7A5GAASMN1; SMN2MAPT
Biphenyl SCHEMBL2494151 0.77 SLC7A5 (0.65) SLC7A5GAASMN1; SMN2MAPT
Carbazole SCHEMBL30528395 0.77 ALDH1A1 (0.67) ALDH1A1GPR3HSD17B10KMT2AMEN1
Carbazole SCHEMBL4786151 0.77 ALDH1A1 (0.67) ALDH1A1GPR3HSD17B10KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8815840-B2 Carbazole and carboline kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2014-08-26 US disclosed
EP-2370407-B1 CARBAZOLE AND CARBOLINE KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2014-06-18 EP disclosed
US-20120058988-A1 CARBAZOLE AND CARBOLINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2012-03-08 US disclosed
EP-2370407-A1 CARBAZOLE AND CARBOLINE KINASE INHIBITORS Bristol-Myers Squibb Company (US) 2011-10-05 EP disclosed
WO-2010080474-A1 CARBAZOLE AND CARBOLINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2010-07-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120058988-A1 CARBAZOLE AND CARBOLINE KINASE INHIBITORS JAK2, JAK1, JAK3 SLC7A5 1879/4885ALDH1A1 1464/4885GPR3 1326/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.